Inclusion Criteria:  Has given informed consent to participate Can read and understand provided patient information material in Danish Biopsy verified PCa  Any, some, or all of the following features:  Prostatic Specific Antigen (PSA) ≥ 20 ng/ml OR Gleason Score ≥ 4+3 OR Tumor stage clinically judged T2c cancer (cT2c) or above as determined by digital rectal exploration and/or transrectal ultrasonography Suspicion of metastases clinically based on other findings Staging by imaging warranted  Exclusion Criteria:  Consent not given Inability to read and/or understand provided patient information in Danish Previously given consent but withdrawn for any reason Staging by imaging not warranted as judged clinically Allergy towards contents in the tracer solution